Loading quotes...
Forecast
The analysts' average price target is €271.67 (-0.81%). The median is €277.65 (+1.37%).
| Buy |
29 |
| Hold |
13 |
| Sell |
1 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Veeva Systems raises annual targets after strong quarter thanks to Vault CRM and AI agents
Veeva Systems beat expectations in the second quarter: revenue rose 18% to $928 million, subscriptions increased 16%, and adjusted earnings per share were $2.35. Management raised the full-year forecast and now expects up to $3.687 billion in revenue and earnings per share of around $9.21. The Vault CRM solution and AI agents were cited as stock drivers, while Veeva continues to expand its market-leading position in the life‑sciences sector. » More on finanzen.net
Veeva deepens AI strategy at Citi Global TMT Conference 2026
Veeva emphasized at the conference that about 98% of revenue still comes from the life sciences sector, commercial subscriptions recently showed roughly 13% year‑over‑year growth, and R&D growth has slowed to mid single‑digit to mid‑teens percentages. The newly positioned Falcon platform is intended to automate agent‑based end‑to‑end workflows, complemented by Vault AI for user‑centric productivity features; pricing for AI products will be transaction‑ and usage‑based to preserve software‑like margins. Veeva signals cautious but accelerated AI deployment, opportunistic acquisitions to speed the roadmap, and is launching Aspen as a standalone CRM initiative outside the core sector. » More on de.investing.com
Veeva Systems establishes itself as operating system of the pharmaceutical industry with a massive moat
Veeva Systems offers cloud software exclusively for the life‑sciences sector and is used by more than 1,500 pharmaceutical, biotech, and medical‑technology companies for clinical trials, regulatory approval, quality, drug safety, and marketing. Products such as Vault CRM, Development Cloud, Quality Cloud, and Data Cloud are deeply embedded in regulated workflows, creating high switching costs and a strong moat. Veeva is targeting a market share of over 70% and sees AI features as extending this competitive advantage. » More on finanzen.net
Veeva exceeds expectations thanks to AI push
Veeva reports better-than-expected revenue and earnings, driven by an AI strategy that CEO Peter Gassner called "the next big chapter." Its core product Vault CRM posted its strongest quarter and is in use at more than 180 customers, including twelve of the 20 largest biopharma companies. The development of agentic AI is also creating new product and growth opportunities. » More on finanzen.net
Veeva Systems beats Q2 expectations and raises full-year outlook
Veeva Systems reported adjusted EPS of $2.35 for the quarter ended July 31 (expectation $2.22) and revenue of $928m (expectation $905.4m). Revenue from commercial subscriptions rose 13%, the company recorded its best CRM quarter and has more than 180 Vault-CRM customers live. Management raised the fiscal 2027 outlook, cited Falcon and other new products as growth drivers, and emphasized the shift to next‑gen R&D offerings. The stock rose about 9.4% in after‑hours trading to $268. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | July 2026 | YoY |
|---|---|---|
| Revenue | 804.36m | 16.44% |
| Gross profit | 603.25m | 16.05% |
| Net profit | 237.01m | 35.16% |
| EBITDA | 312.4m | 29.54% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €44.31bn |
Number of shares | 161.91m |
52-week high/low | €291.97 - €132.60 |
| Dividends | No |
Beta | 0.90 |
P/E ratio | 49.20 |
PEG ratio | 1.99 |
P/B ratio | 6.67 |
P/S ratio | 14.31 |
Company profile
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
| Name | Veeva Systems |
| CEO | Peter Gassner |
| Headquarters | Pleasanton,
ca USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Technology |
| IPO | 06/08/2014 |
| Employees | 7,928 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | VEEV |
London Stock Exchange | 0LO3.L |
XETRA | VEE.DE |
Frankfurt | VEE.F |
Düsseldorf | VEE.DU |
London | 0LO3.L |
SIX | VEE.SW |
München | VEE.MU |
Wien | VEEV.VI |
Milan | 1VEEV.MI |